NewsRoom Articles - Page 39 of 174

MondayMar 20, 2023 9:45 am

HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults

New data show rising burden of most cardiovascular risk factors among young adults aged 20 to 44 in the U.S. Findings are “extremely concerning” as expert notes “we’re witnessing a smoldering public health crisis” HeartBeam has developed the first and only 3D-vector electrocardiogram for heart attack detection anytime, anywhere A recent study shows that risk factors for cardiovascular (“CV”) disease are rising among young adults (https://ibn.fm/jvjFN). Studies like this that provide critical information regarding CV disease highlight the ongoing urgency of HeartBeam’s efforts. HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector electrocardiogram…

FridayMar 17, 2023 11:02 am

Japan to Categorize COVID-19 as Common Infectious Illness

The Japanese government recently announced that the coronavirus will be categorized as a common infectious disease on May 8, 2023. As a result, patients diagnosed with the communicable disease will have to cover medical expenses on their own. In the wake of the coronavirus pandemic in 2020, Japan’s government instituted a special response that limited the number of medical institutions that could handle COVID-19 patients. The upcoming reclassification will classify the coronavirus as a class 5 disease similar to conditions such as seasonal influenza. At the moment, Japan currently classifies COVID-19 as part of a special category that is equal…

FridayMar 17, 2023 9:45 am

Progressive Care Inc. (RXMD) Is ‘One to Watch’

Progressive Care reported a 4% year-over-year revenue increase to approximately $10.1 million for the quarter ended September 30, 2022 The company’s prescription revenue increased 16% year-over-year to almost $9.4 million during that same period In 2022, Progressive Care received nearly $6 million from a strategic investment transaction with NextPlat Corporation The company launched its ClearMetrX platform for 340B third-party administration in 2022 Progressive Care will partner with MedAvail in2023 to provide prescription dispensing kiosks Progressive Care (OTCQB: RXMD) is a health services organization based in Florida that offers personalized healthcare services and technology that supports the managed healthcare industry. Through…

ThursdayMar 16, 2023 11:17 am

Research Finds Link Between Chicken Pox, Cold Sores, Alzheimer’s

Recent research from Tufts University and Oxford University suggests that there may be a link between Alzheimer’s disease (AD) and certain viral infections. The joint research team found that viral infections, such as the common cold sore virus, chicken pox, and shingles, may have some association with the deadly neurological disease. The study sought to understand the link between Alzheimer’s disease and common viruses. The debilitating neural condition is characterized by the damage and death of neurons in the brain that eventually results in brain atrophy and the loss of significant brain volume. More than 6 million Americans live with…

WednesdayMar 15, 2023 10:58 am

How Research on Blood Cancer Could Benefit the Organ Transplant Field

There is a critical shortage of organs within the organ transplant field. Even though there are more than 100,000 people awaiting organ transplants in the United States, there were only 14,903 deceased organ donors last year. The organ shortage crisis in the U.S. and across the globe is taking thousands of lives each year. In the U.S. alone, 13 patients lose their lives to severe kidney disease every day while awaiting a compatible kidney. With around 92,000 people waiting for an organ transplant this year, 1 in 10 of them will have quite a hard time securing a compatible kidney.…

TuesdayMar 14, 2023 12:27 pm

Research Suggests Brain Cancers Could Be Detected Via Blood Tests

The National Brain Tumor Society estimates that around 700,000 Americans live with a primary brain tumor. These tumors can significantly impact patients’ health and quality of life, especially when they aren’t discovered early enough. Reports indicate that 51,329 people died of primary brain cancers and central nervous system tumors (CNS) in 2020; an estimated 18,990 Americans are predicted to lose their lives to brain cancers and CNS this year. Glioblastoma is without a doubt one of the deadliest types of brain cancer. It accounts for 49.1% of all malignant brain tumors, has a five-year survival rate of only 5%, and…

MondayMar 13, 2023 12:28 pm

Study Shows Air Pollution in Urban Areas Worsens Lung Function in Kids

Asthma is a respiratory disease caused by chronic inflammation in the lung airways and is characterized by shortness of breath, chest tightness, wheezing and coughing. It affects an estimated 8.3% of Americans (26.5 million) with 6.1 million being children and 20.4 million being adults. For the most part, asthma attacks are caused by viral respiratory infections that increase inflammation in the lung airways and cause them to narrow. A recent study has now revealed that air pollutants can also increase the risk of asthma attacks. The study found that an increased concentration of air pollutants, especially fine particulate matter and…

MondayMar 13, 2023 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression

A recent medical study found that psychedelic drugs showed promise as a treatment alternative for hard-to-treat depression Psychedelics were found to activate a greater number of serotonin 2A receptors then traditional antidepressant drugs, largely because of their ability to penetrated through cells’ fatty outer membranes The study reinforces the potential use of psychedelic drugs, and psilocybin in particular, as a treatment methodology for a variety of mental health related conditions Silo Pharma, a developmental stage biopharmaceutical company has long focused around merging traditional therapeutics with psychedelic research In a study carried out between 2013 to 2016, researchers found that 8.1%…

MondayMar 13, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leverages Top-Tier Leadership and GMP Facility to Advance Rapid Development of New Therapeutic and Prophylactic Technologies for Multiple Diseases and Disorders

BiondVax is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, primarily for the treatment of infectious and autoimmune diseases The company is led by CEO Amir Reichman, with over 20 years of international experience as a biopharma expert Amir took company reins in 2021 and pivoted the mission and vision including diversifying risks With new focus and opportunity, BiondVax now developing an innovative alpaca-derived nanosized antibody (“NanoAb”) pipeline BiondVax is aggressively advancing new NanoAb therapeutic and prophylactic technologies owing to exclusive collaborations, previous pharma development experience and a state-of-the-art GMP manufacturing facility Leveraging top-tier pharmaceutical industry…

FridayMar 10, 2023 11:13 am

Simple Skin Swab Could Help Predict Future Eczema Risks in Kids

Researchers have found that physicians can predict the future risk of eczema in children via simple skin swabs. Their findings show that collecting cells from the top layers of a week-old baby’s skin using sticky strips can allow doctors to predict whether the infant will develop eczema. Atopic dermatitis (AD) is the most common type of eczema. It is characterized by itchy, dry and inflamed skin. While it can occur at any age, the condition is very common in young children. The condition also increases a patient’s risk of developing asthma, hay fever and food allergies. It affects close to…